Open AccessThe effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels
Author(s) -
Elizabeth Hamlyn,
Wolfgang Stöhr,
David A. Cooper,
Martin Fisher,
Giuseppe Tambussi,
Mauro Schechter,
José M. Miró,
Fiona Vanobberghen,
Abdel Babiker,
Jonathan Weber,
Myra O. McClure,
Kholoud Porter,
Sarah Fidler
Publication year - 2015
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000000675
Subject(s) - medicine , seroconversion , quartile , d dimer , gastroenterology , antiretroviral therapy , area under the curve , biomarker , human immunodeficiency virus (hiv) , immunology , viral load , confidence interval , biochemistry , chemistry
Interruption of antiretroviral therapy (ART) in chronic HIV disease is associated with increased mortality, predicted by elevations in interleukin-6 (IL-6) and D-dimer. The effect of ART interruption in primary HIV-1 infection on these biomarkers is unknown.